Prognostic value of mid-regional pro-adrenomedullin in patients with heart failure after an acute myocardial infarction.
about
MicroRNA and Heart FailureCardiac biomarkers: new tools for heart failure managementNovel biomarkers for cardiovascular risk prediction.ICG-liver test versus new biomarkers as prognostic markers for prolonged length of stay in critically ill patients - a prospective study of accuracy for prediction of length of stay in the ICU.Adrenomedullin and pregnancy: perspectives from animal models to humans.Cardiorenal biomarkers in acute heart failure.Pro-adrenomedullin, pro-endothelin-1, procalcitonin, C-reactive protein and mortality risk in critically ill children: a prospective study.Mid-regional pro-adrenomedullin in acute heart failure: a better biomarker or just another biomarker?Heart failure biomarkers.Novel biomarkers for heart failure.Adrenomedullin and cardiovascular diseasesCardiac biomarkers for infarct diagnosis and early exclusion of acute coronary syndrome.Beyond cardiac troponin: recent advances in the development of alternative biomarkers for cardiovascular disease.Prognostic value of plasma biomarkers in patients with acute coronary syndrome: a review of advances in the past decade.A single nucleotide polymorphism of interleukin-6 gene is related to plasma adrenomedullin levels.Copeptin and MR-proADM in umbilical cord plasma reflect perinatal stress in neonates born to mothers with diabetes and MR-proANP reflects maternal diabetes.Prognostic potential of midregional pro-adrenomedullin following decompensation for systolic heart failure: comparison with cardiac natriuretic peptides.The prognostic value of MR-proadrenomedullin in patients with acute coronary syndrome complicated by cardiogenic shock.Biomarkers in Cardiorenal Syndromes.Proadrenomedullin as a prognostic marker in neonatal sepsis.The Role of Cardiokines in Heart Diseases: Beneficial or Detrimental?MR-proADM as a Prognostic Marker in Patients With ST-Segment-Elevation Myocardial Infarction-DANAMI-3 (a Danish Study of Optimal Acute Treatment of Patients With STEMI) Substudy.
P2860
Q26750638-6DF53D7D-747D-4587-B851-C9878B9721A4Q26991726-78B44B0E-75F9-4974-9D17-CC540F8E1665Q33615459-C1F6FE24-A060-4C99-ABAD-DACAB7724EECQ33909393-60A39DA1-82AB-4688-87A2-CB2EF0AE8701Q36049471-7D0ED031-B841-4005-BCE3-3D91462C0327Q36313675-1D74EF2F-F582-4AB9-8843-948CD9ADCC84Q37343247-E416E61B-B843-4580-828D-37964314981DQ38021707-B99DDF55-08BF-4DAE-9942-9261D0F1ACC6Q38100647-DF28FDB2-DE2B-47A9-8826-452D14D73C40Q38131790-0CB6AAF6-5214-4EFE-88F4-A90BB8529050Q38156783-4C9C339B-D2FD-4588-9692-18952A96C0FAQ38232835-8E328C1A-6196-4FC7-BE20-3974FE7ADD44Q38353580-DBCB627C-5767-4907-B9F7-42B8525ADC61Q38810989-A28C54CF-D659-4925-8634-6F452D1AAD97Q43591587-E2E2D2F5-8E20-482A-8349-82B52FF90041Q45897866-4D7CA105-B9C5-420F-B272-DF28DF50DFA7Q47760332-FEDFE229-6EA1-4513-80A0-C2A6B032F925Q51359233-2EDD1628-1833-4301-9C8A-1B4D6FD2CC7DQ52564486-08C09B39-24BE-40E9-9C06-62D7BC6A3DD1Q53151891-8DF5616A-4A89-48B6-AB95-9F0EC50B1976Q53699115-DEE92D71-F310-43E9-A8A0-E892E1ADDEA2Q55431760-FA41C144-41ED-4CD9-A077-D37D053D13AB
P2860
Prognostic value of mid-regional pro-adrenomedullin in patients with heart failure after an acute myocardial infarction.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Prognostic value of mid-region ...... n acute myocardial infarction.
@en
Prognostic value of mid-region ...... n acute myocardial infarction.
@nl
type
label
Prognostic value of mid-region ...... n acute myocardial infarction.
@en
Prognostic value of mid-region ...... n acute myocardial infarction.
@nl
prefLabel
Prognostic value of mid-region ...... n acute myocardial infarction.
@en
Prognostic value of mid-region ...... n acute myocardial infarction.
@nl
P2093
P50
P356
P1433
P1476
Prognostic value of mid-region ...... n acute myocardial infarction.
@en
P2093
Adriaan A Voors
Hans L Hillege
Iain Squire
Ijsbrand T Klip
Joachim Struck
OPTIMAAL investigators
P304
P356
10.1136/HRT.2010.210948
P407
P577
2011-03-17T00:00:00Z